|
Protocol for Primary Treatment of Snoring by Dentists
Why a
Protocol
Doctors usually arrive at diagnoses and treatments using
an amorphous thought process that lacks structure, and is based
largely on pattern recognition and past clinical experience.
Clinical decision-making arrived at by a progression of well-
reasoned steps may take more time, but arrives at more logical
conclusions and is easier to teach as a new discipline to students
who have little or no experience. Strategies for chunking,
organizing and prioritizing information also help sharpen
doctors’ reasoning skills.
Psychological studies of
scientists demonstrate strong evidence of cognitive limitations
that lead to frequent judgment error and a very limited ability to
deal with complex information. When making clinical decisions,
doctors’ brains have a very limited ability to manipulate
more than four to five variables. Crude non-optimized flow charts
have repeatedly been shown to be more reliable than subjective
human judgment.
A new range of treatment is being proffered to the
dental profession – treatment of benign non-apneic snoring. A
flow chart creates a framework for conceptualization of the problem
and reliable stations for sequential decisions in a logical
progression.
Why a Protocol for Snoring
Snoring is defined as
obstructive sleep breathing. Snoring is caused by diffuse
vibrations or fluttering of pharyngeal tissues during sleep. The
pathogenesis of snoring is vibrating tissues accompanied by
increased collapsibility and incomplete pharyngeal obstruction or
narrowing of the pharyngeal airway. The three necessary conditions
for snoring are vibrating tissue, flow limitation and sleep.
Snoring usually occurs on inspiration but can also occur on
expiration. Snoring can occur during exclusive nasal breathing,
exclusive oral breathing or combined oronasal breathing.
Airflow
velocity during snores usually exceeds that of noiseless sleep
breaths. All people during sleep have increased inspiratory suction
pressure, fast turbulent airflow, increased palatal resistance,
negative inspiratory suction and prolonged inspiratory time.
Snorers during snoring have a greater magnitude of these changes.
The relevant physiological parameters in snorers compared to
non-snorers are upper airway diameter, cross sectional area of the
pharynx, pharyngeal shape, pharyngeal collapsibility, nasal and
pharyngeal resistance to airflow.
The noise of snoring is certainly
disruptive and annoying. Everyone seems to know a snore when they
hear one, but as of August 2008 no gold standard definition of a
snore by objective measurement has been developed. Objective
measurement of snoring has proven difficult. Spectral analysis
reveals a rich complex sound. Attempts to model snoring as coming
from a point-like location have proven futile. Objective
measurement tools to localize the originating site of snores have
not been devised.
Defining snores as a sound have posed more
complex problems. In terms of signal analysis, interpretation,
unique vocal tract characteristics and ideal receiver placement
have presented daunting obstacles. According to Victor Hoffstein,
renowned author of several seminal treatises on snoring, there are
no studies validating the electronic measurement of a sound scored
as a snore by a PSG technician, by a computer or its perception as
a snore by listeners.
A further problem unique to snoring is that
the snorer is usually unaware of the problem, and the initial
complaint is that of the bed partner or listener of the snoring.
The relationship between nasal resistance and snoring is also
complex. When both are measured simultaneously during sleep, no
consistent temporal correlation is found between nasal resistance
and snoring.
Any membraneous part of the upper airway from the nose
to the epiglottis that lacks cartilaginous or bony support may
vibrate. Examples of such structures with vibrating potential are
swollen nasal membranes, soft palate, faucial pillars, pharyngeal
walls, tonsils, adenoids, uvula and tongue.
The health consequences
of snoring range from none (benign clinical sign) to severe sleep
disturbance with morbid consequences, in patients with obstructive
sleep apnea. While snoring usually accompanies OSA, snoring by
itself provides a very low diagnostic predictability for OSA. In a
study of a group of patients who snored, suspected of having OSAand
tested with polysomnography, more than 50% had an AHI less than 10.
Snoring, taken alone as a symptom, has a very low diagnostic
accuracy to predict sleep apnea.
Hoffstein regards an AHI<10 in
the absence of OSA symptoms such as nocturnal cessation of
breathing or awakenings with gasping or choking as the cut-off
defining non-apneic, benign snoring. No studies have implicated
benign non-apneic snoring as being an increased risk factor for
hypertension, vascular disease, heart attack or stroke. Repeated
studies have failed to support an association between benign
non-apneic snoring and decreased daytime cognitive function.
Daytime sleepiness however, is frequently observed in benign non-
apneic snorers. It has been attributed to sleep fragmentation, as a
result of snoring arousals, but the arousal frequency did not
correlate to amplitude or frequency of snores.
So let’s
summarize about snoring. We have not scientifically defined it. We
still don’t know how to measure it. We do not know exactly
where it comes from. No treatment always works. Treatment is
usually not even directed at the snorer. As we shall see, success
of treatment is even hard to define. It is not like dentistry does
not know much about snoring – current medical science does
not know any more.
Why Dentists Should Treat Benign Non-Apneic
Snoring (BNAS)
Dentists are given courses in dental school on
respiratory physiology, oral anatomy, swallowing, tongue function,
orthopedic repositioning of the jaws, and oral prosthetics. Dental
education teaches about the morbidity and consequences of OSA,
diabetes, depression, and obesity. Dental students are schooled in
taking a good medical history and understanding the significance of
their findings. Dentists already do a cancer screening as part of a
routine dental examination. They are already looking at the same
anatomic structures used to determine a referral for diagnosis of
OSA and signs that suggest a patient may be snoring. Further, they
are examining these characteristics based on a higher level of
formal training than most physicians receive in this area. It is
logical and sensible that dentistry as a profession should be among
the very best screeners and referrers of OSA patients to sleep
specialists.
Dentists make oral appliances as a result of their
professional training and the scope of their license. No other
health professional is trained or licensed to make oral appliances.
Oral appliances for benign non-apneic snoring are the least
invasive, highest compliance and most comfortable of the effective
treatments available. Also significant is the fact that benign
non-apneic snoring does not have anywhere near the morbidity of
OSA. Dentists are not trained to treat or deal with the morbid
medical consequences of OSA such as heart attack, stroke, diabetes,
cognitive dysfunction and depression. Dentists are not trained to
manage CPAP or do oral/nasal/palatal surgery. The key question is
whether dentists are qualified to make the differential diagnosis,
“Benign non-apneic snoring or OSA?”
Making the
Differential Diagnosis and Evaluating Treatment Outcome
In oral
appliance therapy for snoring and sleep apnea, a reliable
ambulatory testing device to establish baseline OSA levels and
evaluating treatment outcome is an essential requirement. Ideally
an ambulatory PSG device would measure obstructive apneas, central
apneas, mixed apneas, hypopneas, oral/nasal airflow resistance,
AHI, desaturations, blood oxygen level, pulse rate, body position,
and snoring.
One such device is the Braebon Medibyte, an
FDA approved miniature 12 channel Class 2 ambulatory
polysomnographic recorder. The patient easily connects an abdominal
belt, a chest belt that holds the recorder, a nasal/oral cannula, a
pulse oximeter and a tiny snore microphone. They sleep in the
comfort of their own bed at home.
The software allows the doctor to
evaluate the entire study, rescore any events or accept the
computer interpretation. It records snores in decibels and allows
the user to click and listen to any snore or series of snores
desired. The Medibyte is unique among ambulatory PSG units in that
it records snoring at a high enough sampling rate to allow spectral
analysis of the snore sound from 0 – 1000 Hz. As such, it is
also a valuable research tool. The cost of the Medibyte is very
reasonable, the cost per study for expendables is cheap and the
reliability is excellent. The data is presented in a language that
facilitates excellent communication and reports to referring
doctors. It allows a clinician to practice at the state of the
science and retest patients as frequently as needed to get it
right.
A baseline recording is taken on all sleep/snoring patients
as the initial measurement against which treatment outcome can be
evaluated. A second recording is done two to three weeks following
delivery and fitting of the oral appliance, when the patient has
had sufficient time to adjust to wearing their intraoral device.
Subsequent recordings are done after each appliance adjustment.
Treatment results of oral appliances on benign non-apneic snoring
can be objectively measured. Frequency of snores, loudness of the
loudest snores, average loudness of snores, and number of snores
per hour can all be measured. The problem of patients with benign
non-apneic snoring may not be the effect of snoring and the
appliance on them but on their sleep partner. Reduction of
frequency and loudness of snores may not be as meaningful as the
sensitivity of the sleep partner. How good is their sleep quality?
How far away do they sleep? How good is their hearing? How big is
the bed? There is no gold standard to objectively measure treatment
success for snoring.
Defining Successful Treatment of Benign
Non-Apneic Snoring On the flow sheet for diagnosis and treatment of
benign non-apneic snoring we should logically be able to say that
treatment outcome is either unsuccessful, is a qualified success or
successful. The difficulty is defining these outcome possibilities.
Criteria and standards based on physiologic validation obtained by
objective measurement is an ideal. In sleep medicine many
definitions are arbitrarily set and not based on scientifically
validated parameters. The definition of
“CPAP compliance” is arbitrarily set. The parameters
defining mild, moderate and severe obstructive sleep apnea are
arbitrarily set. Research criteria for success of oral appliance
therapy for OSA, 50% reduction of AHI, AHI below 10, or both, are
arbitrary. Rejection of payment for UARS by insurance companies and
rejection of payment for OSA if the AHI is below 10 are arbitrary
and not based on any scientific criteria.
There are numerous
possible criteria for evaluation of successful treatment of benign
non-apneic snoring. Some are subjective. Some are based on
objective measurement. All are arbitrarily set standards.
Subjective Criteria • Patient is comfortable with their
appliance
• Patient is compliant wearing their appliance
• Patient reports a subjective improvement in sleep quality
• Patient’s bed partner is satisfied
Objective Criteria
• Patient snoring is worst when sleeping supine, position
training is appropriate
• Reduction in loudest decibel score
• Reduction in average decibel score of snores recorded
•
Reduction in number of snores recorded above 65 decibels
•
Reduction in number of events of resistance to oral/nasal airflow
as measured by the pressure transducer in the cannula.
Discussion
In an ideal world the subjective criteria could be scored on a
visual analog scale (VAS), graded 1 – 5. Numeric values of 1
– 5 could also be assigned for the scoring of objective
criteria and a scale devised such as the Epworth Sleepiness Scale.
It is the opinion of this clinician that a scale is not appropriate
for evaluation of therapy for snoring. The state of sleep science
is such that snoring is too heterogeneous a problem for a single
number to represent all the factors necessary to determine success
at treatment of snoring. There is an ongoing debate in the sleep
community whether snoring is under central control or peripheral
mediation by anatomic characteristics. Snoring is a complex multifactorial problem whose etiology may vary from patient to
patient.
Should research scientists devise a study to test the
minimum snore loudness in decibels that cause arousals in a
population of snorers? The results would most likely fall into a
Bell Curve. An average score on such an objective study would not
be representative of a successful treatment standard for many
snorers. Also the study would have to be repeated on the sleep
partners of the snorers because it is often their arousal level
that determines both the need for therapy and the measure of
success of the snoring therapy. Hearing acuity varies in a
population as well as physiological arousal level from snores. The
uniqueness of each patient’s physiological and anatomic
characteristics, the limitations of scientific knowledge of snoring
and the limitations of each available therapy must be appreciated
in determining clinical success.
Defining successful treatment of
snoring is an elusive concept. Physiological perfection is not an
easily attainable goal. Present therapies do not cure patients of
the etiological factors causing the snoring. Success of treatment
is mutually agreed upon on an individual case basis by clinician
and patient, and in many cases the sleep partner. The operative
word is often satisfaction. Trial and error, patience by the
clinician and patient and confidence in the relationship are all
variables determining satisfaction. “Qualified success”
reflects improvement in criteria before all possible alternatives
have been tried and evaluated. Successful treatment using
“The Protocol” is based on maximum improvement
attainable using an oral appliance. The clinician and patient
should be satisfied and agree that all possible alternatives have
been tried. Following “The Protocol” assures
thoroughness that all paths are explored. “The
Protocol” is merely a roadmap.
Summing it Up
There is no
convincing evidence that benign non-apneic snoring will predictably
advance to morbid health consequences as a continuum in the
progression of OSA. “The Protocol” is a guide and
reminder that snoring is a complex, heterogeneous problem that may
require involvement of multidisciplinary health care specialists.
There is no one therapy that always works to control snoring. The
success of oral appliances for treatment of snoring is a
well-documented fact. Dentists having the correct measurement
devices and training are logical health care specialists for
diagnosis and treatment of benign non-apneic snoring. Following
this protocol, dentists involved in the diagnosis and treatment of
benign non-apneic snoring should also be the best resource for
referral of OSA patients to sleep specialists.
Allen J. Moses, DDS,
DABCP, DABDSM is the Professor of Rush University Medical School's
Department of Sleep Disorders in Chicago, Illinois; a Diplomat of
The American Academy of Dental Sleep Medicine; and a Diplomat of
The American Academy of Cranial Facial Pain.Journal
List
|